Betazole

Betazole
Names
	IUPAC name 2-(1H-Pyrazol-5-yl)ethan-1-amine
Identifiers
CAS Number	105-20-4 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:59170 ;
ChEMBL	ChEMBL1201323 ;
ChemSpider	7455 ;
DrugBank	DB00272 ;
ECHA InfoCard	100.002.981
IUPHAR/BPS	7126;
PubChem CID	7741;
UNII	1C065P542O ;
CompTox Dashboard (EPA)	DTXSID7022675 ;
	InChI InChI=1S/C5H9N3/c6-3-1-5-2-4-7-8-5/h2,4H,1,3,6H2,(H,7,8) Key: JXDFEQONERDKSS-UHFFFAOYSA-N ; InChI=1/C5H9N3/c6-3-1-5-2-4-7-8-5/h2,4H,1,3,6H2,(H,7,8) Key: JXDFEQONERDKSS-UHFFFAOYAY;
	SMILES n1ccc([nH]1)CCN;
Properties
Chemical formula	C5H9N3
Molar mass	111.145 g/mol
Pharmacology
ATC code	V04CG02 (WHO)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Betazole (also known as ametazole) is a histamine H₂ receptor agonist. Betazole hydrochloride is known as gastramine and histalog.

It has been used as a gastric stimulant to test for maximal production of gastric secretion activity.^[1] The test can be used in diagnosis of diseases such as Zollinger-Ellison syndrome where there is excess acid production, in this case driven by over production of gastrin. The volume of acid secretion is measured following administration of betazole, diagnosis being secretion greater than 60% of the maximal acid secretion following betazole stimulation. This procedure can lead to complications and should be avoided in subjects with coronary artery disease.^[2] It is also used in diagnosis of gastritis in association with a test for secretin activity.

Betazole is used as a stimulant in preference to histamine because of its specificity for the H₂ receptor and its advantage of not generating the undesirable side effects that histamine would induce. It therefore does not require concomitant use of antihistaminic compounds to block the actions of histamine at other histamine receptor types.

It is used to test the effectiveness of H₂ receptor blocking drugs such as nizatidine.^[3]

References

^ Wruble LD Cummins AJ Goldenberg J Schapiro H (1967). "The effect of intravenous histalog on gastric secretion in man". Digestive Diseases and Sciences. 12 (11): 1087–1090. doi:10.1007/BF02233873. PMID 6057052. S2CID 8990827.
^ Stoller JL Holubitsky IB Harrison RC Munro AI (1970). "Complications of the histalog test of gastric acid secretion". Digestive Diseases and Sciences. 15 (7): 647–651. doi:10.1007/BF02236024. PMID 4951403. S2CID 37678802.
^ Hammond JB, Offen WW (1988). "Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin". Am J Gastroenterol. 83 (1): 32–6. PMID 2892392.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

[1] Wruble LD Cummins AJ Goldenberg J Schapiro H (1967). "The effect of intravenous histalog on gastric secretion in man". Digestive Diseases and Sciences. 12 (11): 1087–1090. doi:10.1007/BF02233873. PMID 6057052. S2CID 8990827.

[2] Stoller JL Holubitsky IB Harrison RC Munro AI (1970). "Complications of the histalog test of gastric acid secretion". Digestive Diseases and Sciences. 15 (7): 647–651. doi:10.1007/BF02236024. PMID 4951403. S2CID 37678802.

[3] Hammond JB, Offen WW (1988). "Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin". Am J Gastroenterol. 83 (1): 32–6. PMID 2892392.

[1]

[2]

[3]